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	 Objective	 To validate the Hong Kong Chinese translation of the Overactive 
Bladder Symptom Score questionnaire (OABSS-HKC).
	 Design	 Cross-sectional study.
	 Setting	 Five urology clinics of different regional hospitals in Hong Kong.
	 Participants	 The Overactive Bladder Symptom Score questionnaire was 
translated and culturally adapted for Hong Kong Chinese, 
according to the Principles of Good Practice for the Translation 
and Cultural Adaptation Process for Patient-Reported 
Outcomes Measures. Chinese-speaking patients with overactive 
bladder symptoms were recruited from five urology clinics. 
The patients completed the OABSS-HKC, a 3-day micturition 
diary, International Prostate Symptom Scores, and the Patient 
Perception of Bladder Condition questionnaires, and again 
after a 2-week interval (that is, on two occasions). Test-retest 
reliability was evaluated by the intraclass correlation coefficient 
and weighted Kappa coefficient. The relationship between 
OABSS-HKC total scores and items in the comparison measures 
was evaluated using Spearman’s correlation coefficients.
 Results The OABSS-HKC was successfully translated and culturally 
adapted. Fifty-one patients completed the validation study. 
A high level of reliability was observed between the OABSS-
HKC total score answered at visit 1 and 2 for all subjects 
(intraclass correlation coefficient, 0.82) and among the four 
items answered (weighted Kappa coefficients, 0.57-0.75). The 
OABSS-HKC total score correlated significantly with numbers 
of micturitions, incontinence and urgency episodes recorded 
in the 3-day micturition diary, as well as the total International 
Prostate Symptom Scores and the Patient Perception of Bladder 
Condition score. However, the OABSS-HKC total score was not 
significantly associated with nocturia episodes, total voided 
volume, or number of pads used.
	 Conclusions	 The OABSS-HKC total scores are reliable and moderately valid 
for the quantitative evaluation of overactive bladder symptoms 
in Hong Kong Chinese-speaking adults.
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Introduction
Overactive bladder (OAB) is initially diagnosed based only on symptoms, without 
recourse to tests of urodynamic functions. It comprises symptoms of urinary urgency (a 
prerequisite for the diagnosis), urinary frequency (daytime and nighttime) with or without 
urge incontinence. According to the International Continence Society (ICS) year 2002 
terminology,1 localised conditions such as bladder tumours, bladder calculi, and urinary 
New	knowledge	added	by	this	study
• The newly translated and culturally adapted Hong Kong Chinese version of the Overactive 
Bladder Symptom Score questionnaire (OABSS-HKC) is reliable and moderately valid for 
quantitative evaluation of the relevant symptoms in local Chinese-speaking patients.
Implications	for	clinical	practice	or	policy
• The existing instruments measuring overactive bladder symptoms mainly focus on their 
effects on daily living (not on the symptoms per se), and difficult to self-administer.
• The OABSS-HKC is an easy-to-use and validated patient-reported outcome measure for 
evaluation of overactive bladder symptoms.
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tract infections must first be ruled out. Moreover, 
OAB, especially with incontinence, is reported to 
have a significant influence on quality of life (QOL).2,3
 The prevalence of OAB based on ICS definitions 
has varied in different epidemiological studies. 
According to the US Census Bureau international 
database, worldwide OAB prevalence in 2008 was 
10.7% and is expected to reach to 20.1% by 2018.4 
Especially in Asia, it is expected to increase markedly 
(to 24.4% by 2018).4
 According to the World Population Ageing 2009 
published by the United Nations, those aged 60 years 
or above in Hong Kong accounted for 17.7%, the 
median population age in 2009 being 41.4 years.5 By 
2050, at least half of Hong Kong population will be 
aged 55 years or above and have the highest mean 
age in the world. With these predictions, in the near 
future the number of patients with OAB will increase 
substantially in Hong Kong.
 Serial questionnaires measuring OAB 
symptoms are currently available, namely: the 
Overactive Bladder Questionnaire, the Patient 
Perception of Bladder Condition (PPBC), the Urgency 
	 目的	 驗證膀胱過度活動症症狀評分表的香港中文翻譯版本
（OABSS-HKC）。
	 設計	 橫斷面研究。
	 安排	 香港不同分區醫院的五間泌尿科診所。
	 參與者	 根據翻譯和文化適應患者報告結果措施的良好實踐原
則，把膀胱過度活動症症狀評分表翻譯成中文，並在
翻譯過程中作了香港文化上的適應。五間泌尿科診所
中的漢語膀胱過度活動症患者參與本研究。患者完成
了OABSS-HKC、為期三天的排尿日記、國際前列腺
症狀評分表（IPSS）及患者膀胱狀況之感受的問卷
（PPBC），並於兩週後再完成同樣的問卷。利用組
內相關系數和加權Kappa系數評估問卷的重測信度。
最後用Spearman相關系數評估OABSS-HKC的總分和
比較措施中各項的關係。
	 結果	 成功把OABSS翻譯成香港中文版，並根據本港文化
改編。51名參與者完成驗證研究。所有參與者於第一
次和第二次訪問中，OABSS-HKC總分（組內相關系
數=0.82）及四個項目（加權Kappa系數=0.57-0.75）
均有高水平的信度。OABSS-HKC總分與記錄在三天
排尿日記中的排尿次數、尿失禁和緊迫性發作次數
顯著相關，亦與IPSS總分和PPBC得分明顯相關。然
而，OABSS-HKC總分與夜尿發作、總排尿量及使用
墊的數目沒有顯著關係。
	 結論	 OABSS-HKC總分對於定量評估香港漢語膀胱過度活
動症成年患者屬可靠，並適度有效。
膀胱過度活動症症狀評分表（中文版）的 
信度和效度
Questionnaire, and the Primary OAB Symptom 
Questionnaire. The reproducibility of these tools 
have been investigated,6,7 but none are employed 
as a patient-reported outcome (PRO) measure for 
symptoms and QOL. Moreover, these instruments 
mainly focus on the effects of OAB on daily living 
and not on OAB symptoms. An Overactive Bladder 
Symptom Composite Score (OAB-SCS), on the other 
hand, can quantitatively evaluate OAB symptoms 
through the Indevus Urgency Severity Scale, 
which evaluates all voiding symptoms and urgency 
incontinences.8 However, the OAB-SCS is a tedious 
and difficult instrument for patients to administer as 
it involves a micturition diary.
 The Overactive Bladder Symptom Score 
questionnaire (OABSS) was originally developed by 
Homma et al9 in 2006 to evaluate OAB symptoms. The 
questionnaire was developed in Japanese. Unlike 
other questionnaires measuring OAB, the OABSS 
makes evaluation of relevant symptoms possible as 
a single index. An OABSS total score is the sum of 
scores of several items—namely: daytime frequency, 
nighttime frequency, urgency, and urgency 
incontinence—the OABSS is, therefore, regarded 
as a PRO measure (one-stop test) without the need 
to complete a 3-day micturition diary. Moreover, the 
OABSS has been shown to have high sensitivity for 
treatment-related changes in OAB symptoms among 
Japanese patients.10
 To turn the original OABSS into Hong Kong 
Chinese (HKC), the key element was not only 
dependent on an accurate linguistic translation but 
also required a conceptual and cultural equivalence. 
A widely accepted international standard for 
translation and cultural adaptation (TCA) of PRO 
measures is the Principles of Good Practice for the 
Translation and Cultural Adaptation Process for 
Patient-Reported Outcomes Measures.11
 The primary objective of this study was to 
evaluate the test-retest reliability of the HKC version 
of the OABSS (OABSS-HKC). The secondary objective 
was to validate the OABSS-HKC by evaluating its 
correlation with the existing standard OAB evaluation 
measures, namely: the 3-day micturition diary, 
International Prostate Symptom Scores (IPSS) and its 
QOL score, and the PPBC.
Methods
Translation	and	cultural	adaptation	process
The developer of the OABSS was contacted and 
permitted the authors to turn the OABSS Japanese 
version (source) into a HKC version. The source 
was translated and culturally adapted into the HKC 
version in accordance with the Principles of Good 
Practice for TCA Process for PRO Measures.11 The 
TCA process included the following steps:
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1. Learning from the developer (Dr Homma) of the 
source on the conceptual basis of each item of 
the source. 
2. Independent forward translation by two 
translators who were native speakers of HKC and 
fluent in Japanese.
3. Reconciliation of the two translated versions into 
a reconciled HKC version.
4. Independent backward translation on the 
reconciled HKC version by two translators who 
were native Japanese speakers and fluent in HKC.
5. Review of back translations against the source 
for discrepancies. Dr Homma was consulted and 
resolved the difficult issues. The HKC translation 
was revised accordingly and the second-
reconciled HKC version was produced.
6. A urologist, two other clinicians, and one urology 
nurse reviewed and fine-tuned the version into 
the third-reconciled HKC version.
7. Cognitive debriefing—the third-reconciled 
HKC version was self-administered by Chinese-
speaking patients with OAB to assess their level 
of comprehension and cognitive equivalence of 
the translation. Before the cognitive debriefing 
study, ethics approval was obtained for conduct 
of the study. All patients who participated were 
asked to provide written informed consent prior 
to enrolment. 
8. The cognitive debriefing results were reviewed 
and the translation was modified into the fourth-
reconciled HKC version.
9. After proofreading on spelling and formatting 
of the translation, a final OBASS-HKC was 
developed.
The	validation	process
A validation study of the final OABSS-HKC was 
conducted in five urology clinics of different regional 
hospitals serving an estimated population of 5 million 
in Hong Kong between October 2009 and February 
2011. Male or female patients aged 18 years or older, 
with symptoms of OAB for at least 3 months and more 
than one episode of urinary urgency with or without 
urgency incontinence in the prior 3 days, were 
eligible to be screened in the study clinics. Patients 
were excluded if they predominantly had stress 
incontinence (as determined by the investigator), an 
indwelling catheter or were practising intermittent 
self-catheterization, a symptomatic urinary tract 
infection or chronic inflammation, had started an OAB 
treatment that was stopped or changed in the last 4 
weeks, or had diabetic neuropathy. Written informed 
consent was obtained from patients prior to screening.
 At screening, the investigators instructed 
the patients on how to record information on the 
micturition diary for 3 days prior to visit 1 (week 0) 
and visit 2 (week 2). The diary recorded the number of 
micturitions, and episodes of urgency, incontinence, 
nocturia, as well as volume of each void and number 
of incontinence pads used for 3 days prior to each 
visit. Recording for 1 day started when patients woke 
up and ended on the following day when the patient 
woke up.
 At visit 1, the diary was assessed by the 
investigator for confirmation of patient eligibility. 
Patients had to have at least eight micturitions per 
day and at least one urgency episode as per record 
in the diary. Patients who did not complete the 3-day 
micturition diary according to instructions were 
excluded at visit 1. Eligible patients were asked to 
complete the second 3-day micturition diary over 3 
days prior to visit 2. At both visits, patients completed 
the questionnaires, namely: the OABSS-HKC, IPSS 
and IPSS-QOL, and the PPBC.
 During the study, indwelling catheters and 
intermittent self-catheterization were prohibited. 
Initiation of medications (namely, anticholinergics/
antispasmodics, anti-Parkinson drugs), α-antagonists, 
and tricyclic antidepressants (namely, amitriptyline 
and imipramine) were not allowed. Patients were 
not allowed to change dosages of any concomitant 
medications, namely, antidepressants (tri-and tetra-
cyclic), antihistamines or antimetics, loop diuretics, 
neuroleptics, type I antiarrhythmics, and opioids.
 Ethics approval was granted for the conduct 
of the study at each site. The study was conducted 
in accordance with International Conference on 
Harmonisation Good Clinical Practice guidelines and 
Declaration of Helsinki. 
 A sample size was calculated in order to archive 
an accuracy of parameter estimate, namely OABSS-
HKC total score. Forty evaluable subjects were 
found to be required. In consideration of possible 
exclusions or dropout rates, the study planned to 
recruit up to 80 subjects. Descriptive statistics were 
calculated to summarise the demographic and clinical 
characteristics of patients. All statistical tests were 
two-tailed with a significance level of 0.05. Test-retest 
reliability was examined by calculating the intraclass 
correlation coefficient (ICC) for the OABSS-HKC 
total score, and weighted Kappa coefficients for each 
individual symptom score. Spearman’s correlation 
coefficients were calculated to assess the degree of 
association between the OABSS-HKC total score and 
individual variables recorded in the 3-day micturition 
diary, the IPSS total score, and scores for IPSS-QOL and 
PPBC at visits 1 and 2. A correlation coefficient of 0.1 
was considered small, 0.3 was moderate, and ≥0.5 was 
large, following the guidelines proposed by Cohen.12
Results
The	translation	and	cultural	adaptation	process
During the TCA process, only minimal cultural and 
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conceptual difficulties were encountered. The 
difficulties were resolved and conceptual equivalence 
in translations was reached by going through the 
reconciliations. In the cognitive debriefing, five 
patients with OAB symptoms administered the 
third-reconciled OABSS-HKC. The patients were 
interviewed by the study team about their views on 
the questionnaire. All the patients considered that 
the overall relevance and clarity of the questionnaire 
was moderate or high. They all found the length of 
the questionnaire acceptable and no unclear or 
irrelevant item in the questionnaire. The patients had 
no comments on the content of the questionnaire 
except that two of them found the presentation of 
the scoring system at the bottom of the table unclear, 
and suggested presenting the scoring system in a 
table format. The presentation of the scoring system 
was then modified. The reconciled translations were 
adjusted and the final OABSS-HKC was developed 
(Table 1).
The	validation	study
Disposition and background characteristics of patients
Sixty-five patients were enrolled from a pool of 
approximately 900 new cases with OAB symptoms 
in approximately 15 months. Fourteen patients were 
excluded from the study (two were ineligible for 
screening, five had not completed the first 3-day 
micturition dairy, and seven the second micturition 
dairy). There were no significant differences in 
patient demographics and clinical characteristics 
between the 14 excluded patients and the remaining 
51 patients. 
 The remaining patients in the study included 
30 (59%) males and 21 (41%) females. Among them, 
47 (92%) patients had at least three or more urgency 
episodes with or without incontinence at baseline 
assessment. Patient demographic and clinical 
characteristics are summarised in Table 2.
Reliability	study	
A high level of reliability was observed between the 
OABSS-HKC total score answered at visits 1 and 2 for 
all subjects (ICC=0.82; 95% confidence interval [CI], 
0.71-0.89). A high level of correlation was observed 
among individual OABSS symptom scores between 
the two visits, with the weighted Kappa coefficients 
for the individual item of the OABSS-HKC as follows: 
daytime frequency, 0.57 (95% CI, 0.32-0.83); nighttime 
frequency, 0.75 (95% CI, 0.64-0.87); urgency, 0.61 (95% 
CI, 0.46-0.77); and urgency incontinence, 0.74 (95% 
CI, 0.62-0.85).
TABLE 1.  Hong Kong Chinese version of Overactive Bladder Symptom Score 
(OABSS-HKC) [膀胱過度活躍徵狀問卷] 
Copyright reserved by Dr Yukio Homma and Dr Ming-kwong Yiu.  The OABSS 
Hong Kong Chinese version may be copied and used without permission from the 
copyright holders only for the purpose of medical care or research of overactive 
bladder symptoms 
以下的徵狀有多頻密？請就您最近一星期的狀況，選擇一個最接近的頻密程度，並
將分數欄內相應數字圈出來。
問題 徵狀 頻密程度 分數
1 由早上起床開始至晚上睡覺為止，大約小
便了多少次？
7次或以下
8~14次 
15次或以上
0
1
2
2 由晚上睡覺至早上起床為止， 為了小便而
起床的次數大約有多少次？
0次
1次
2次
3次或以上
0
1
2
3
3 有沒有試過突然感到尿急， 覺得難以忍
受？
沒有
1星期少過1次
1星期1次或以上
大約1日1次
1日2~4次
1日5次或以上
0
1
2
3
4
5
4 有沒有試過突然感到尿急而達致漏尿？ 沒有
1星期少過1次
1星期1次或以上
大約1日1次
1日2~4次
1日5次或以上
0
1
2
3
4
5
總分數（OABSS）                  分
有膀胱過度活躍徵狀： 問題3的分數≥2分，並且總分數≥3分
徵狀程度： 總分數 3至5分：輕度
總分數 6至11分：中等度
總分數 ≥12分：重度
TABLE 2.  Patient demographics and background characteristics 
(n=51)
Parameters No. (%) of patients*
Age (years)
Mean ± standard deviation 53 ± 13
Median (range) 53 (26-86)
Gender
Male 30 (59%)
Female 21 (41%)
Body mass index (kg/m2)
Mean ± standard deviation 24 ± 3
Median (range) 24 (18-34)
History of overactive bladder
3 Months - 1 year 11 (22%)
1-5 Years 26 (51%)
>5 Years 14 (27%)
No. of urgency episodes†
1 or 2 4 (8%)
3 to 5 17 (33%)
≥6 30 (59%)
* Unless otherwise stated
† No. of urgency episodes with or without incontinence in the last 
3 days
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 As shown in Table 3, the ICC indicated a fair-
to-strong association between answers to each of the 
variables in the standard measures at visits 1 and 2.
Construct	validity	study	
Construct validity was evaluated using the OABSS-
HKC total score and the variables in the standard 
measures (Table 4). The OABSS-HKC total score 
correlated strongly with the number of incontinence 
episodes at visit 1 (r=0.406; P<0.05) and visit 2 (r=0.576; 
P<0.001) recorded in the diary and PPBC score at visit 
1 (r=0.516; P<0.001) and visit 2 (r=0.499; P<0.001). The 
correlation was moderate to high for the number 
of micturition and urgency episodes recorded in 
the diary and the IPSS total score and QOL. The 
correlations were low for the number of nocturia 
episodes, voided volumes, and number of pads used.
Discussion
The OABSS developed by Homma et al in 20069 has 
been translated into various languages around the 
world, and widely employed for its utility. However, 
there are always reservations about a questionnaire 
developed by and for differing ethnic groups. This 
is because the symptoms and complaints expressed 
with a functional disorder such as OAB can vary with 
differing dispositions, such as social circumstances 
and regions, patient gender, age, individual 
conditions, or environments. Thus, the OABSS-HKC 
version was translated and culturally adapted in 
accordance with international guidelines. With the 
translated and culturally adapted OABSS-HKC, the 
study was conducted to evaluate whether or not the 
Japanese-developed OABSS was also valid for Hong 
Kong Chinese-speaking patients.
 The test-retest reliability was high for the 
OABSS-HKC total score and each of the four 
constituents after a 2-week interval. The OABSS-
HKC total score was correlated with the number of 
micturition, incontinence and urgency episodes 
recorded in the 3-day micturition diary, and other 
measures namely: the scores for IPSS, IPSS-QOL, and 
PPBC. The results suggest that the OABSS-HKC is a 
reliable and moderately valid PRO measure for OAB 
symptoms. The OABSS-HKC can be an alternative to 
the micturition diary for OAB symptom assessment 
in case patients or caregivers who are not capable in 
managing a micturition diary.
 One limitation of the study was that the 
patients’ answers to the OABSS-HKC may have 
been influenced by what the patients recorded in 
the micturition diaries in the previous 3 days. We 
believe such influence was minimised because all 
the patients were asked to record the requested 
events on the diary when they occurred (real-time 
recording) during those 3 days. At the study visits, all 
patients were asked to recall the events that occurred 
in the past 1 week and not just the past 3 days and 
record the answers in the OABSS-HKC. The patients 
were not allowed to read out from the diary while 
filling in the OABSS-HKC. Another limitation of the 
study was that the weights (scale of score) given to 
the individual items could influence the strength of 
associations with items in the micturition diary.
 Notably, the nocturia episodes, total urine 
voided volumes, and number of pads used recorded 
in the diary were not significantly associated with 
the OABSS-HKC total score. This may be explained 
by the kind of pads used in this study not being 
standardised; a strong personal preference was 
TABLE 3.  Test-retest reliability by intraclass correlation coefficient between variables 
or scores at visits 1 and 2*
Measure Item ICC (95% CI)
3-Day micturition diary No. of micturition 0.796 (0.670-0.878)
No. of incontinence 0.802 (0.677-0.881)
No. of urgency 0.744 (0.592-0.845)
No. of nocturia 0.832 (0.723-0.900)
Total voided volume 0.786 (0.655-0.872)
No. of pads used 0.928 (0.878-0.958)
IPSS Total score 0.851 (0.753-0.912)
QOL score 0.649 (0.459-0.783)
PPBC PPBC score 0.636 (0.440-0.774)
* ICC denotes intraclass correlation coefficient, CI confidence interval, IPSS International 
Prostate Symptom Scores, PPBC Patient Perception of Bladder Condition, and QOL 
quality of life
TABLE 4.  Spearman’s correlation coefficients between OABSS-HKC total score and 
variables in 3-day micturition diary, IPSS total score, IPSS-QOL, and PPBC at visits 1 
and 2*
Measures Item OABSS-HKC total score 
coefficient
Visit 1 Visit 2
3-Day micturition diary No. of micturition 0.422† 0.338†
No. of incontinence 0.406† 0.576‡
No. of urgency 0.298† 0.439†
No. of nocturia 0.241§ 0.221§
Total voided volume 0.161§ 0.253§
No. of pads used 0.233§ 0.101§
IPSS Total score 0.283† 0.323†
QOL score 0.284† 0.486‡
PPBC PPBC score 0.516‡ 0.499‡
* OABSS-HKC denotes the Hong Kong Chinese version of the Overactive Bladder Symptom 
Score questionnaire, IPSS International Prostate Symptom Scores, QOL quality of life, 
and PPBC Patient Perception of Bladder Condition
† P<0.05
‡ P<0.001
§ P>0.05
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involved in changing of pads. In addition, there are 
concerns about the accuracy of the voided volumes 
measured by the patients and recall of nocturia 
episodes in the morning.
 The IPSS total score in this study showed 
significant correlations with OABSS-HKC total score, 
and concerns elements of voiding dysfunction and 
bladder storage symptoms. While it was established 
as a questionnaire to evaluate benign prostate 
hyperplasia (BPH) symptoms, the relevant signs 
and symptoms are similar to those of OAB patients. 
To date, it is the best available scoring tool used in 
clinical practice for OAB. The IPSS total score and 
various markers are used to evaluate the potency of 
BPH drugs, and the OABSS total scores are sometimes 
used simultaneously and are reported to yield similar 
outcomes.13,14
 Notably, there was a strongly significant 
correlation between the OABSS-HKC total score and 
PPBC, which was similar to the findings of Homma 
and Gotoh.15 In another recent report by Homma 
et al,10 there was high correlation between OABSS 
total scores and 3-day micturition diary items, that 
were reported to yield high sensitivity for detecting 
OAB changes following treatment. In general, such 
findings are also in agreement with the results of this 
study and those report by Xu et al.16 Another definite 
limitation of the current OABSS-HKC validation study 
was that the responsiveness to treatment was not 
evaluated, but further studies to look into this are 
planned.
 Patients with OAB are often classified as 
incontinent (OAB wet) or without incontinence 
(OAB dry). Patients with incontinence obviously 
have lower QOLs than those without. In the report 
by Homma et al,9 the OABSS total score distributions 
clearly differed in the two groups. Future studies in 
OAB patients need to use this classification. 
Conclusions
The OABSS-HKC total score has high reproducibility 
and correlated with most of the variables in the 
micturition diary, the IPSS, and the PPBC. The OABSS-
HKC total score is reliable and moderately valid for 
quantitative evaluation of OAB symptoms of Hong 
Kong Chinese-speaking patients.
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